Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.

Chloe Orkin,Keikawus Arastéh,Miguel Górgolas Hernández-Mora,Vadim Pokrovsky,Edgar Turner Overton,Pierre-Marie Girard,Shinichi Oka,Sharon Walmsley,Chris Bettacchi,Cynthia Brinson,Patrick Philibert,Johan Lombaard,Marty St. Clair,Herta Crauwels,Susan L. Ford,Parul Patel,Vasiliki Chounta,Ronald D'Amico,Simon Vanveggel,David Dorey,Amy Cutrell,Sandy Griffith,David A. Margolis,Peter Williams,Wim Parys,Kimberly Y. Smith,William Spreen

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.

2020

Abstract Background Long-acting injectable regimens may simplify therapy for patients with human immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3, randomized, open-la...

Keywords:

Internal medicine
Surgery
Rilpivirine
Medicine
Diabetes mellitus
Cabotegravir
human immunodeficiency virus
long acting

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations